CAG repeat length polymorphism in the androgen receptor gene and breast cancer risk: Data on Indian women and survey from the world

Breast Cancer Research and Treatment

Volumn 127, Issue 3, 2011, Pages 751-760

  Rajender, Singh ^a,b   Francis, Amirtharaj ^c   Pooja, Singh ^b   Krupakar, Nallala ^a   Surekha, D ^d   Reddy, Gopal ^e,f   Rao, D Raghunatha ^g   Rao, Lakshmi ^h   Ramachandra, S ^h   Vishnupriya, S ^d   Ramalingam, K ^c   Satyamoorthy, K ⁱ   Thangaraj, Kumarasamy ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

^c Government Arts College for Men (Autonomous)   (India)

^d OSMANIA UNIVERSITY   (India)

^e MNJ Cancer Hospital   (India)

^f OSMANIA GENERAL HOSPITAL   (India)

^g NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

^h KASTURBA MEDICAL COLLEGE   (India)

ⁱ MANIPAL UNIVERSITY   (India)

Author keywords

Androgen receptor; Breast cancer; CAG repeat polymorphism

Indexed keywords

ANDROGEN RECEPTOR; BRCA1 PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CAG REPEAT; CANCER STAGING; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE MUTATION; HUMAN; INDIAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANDROGENS; BREAST NEOPLASMS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDIA; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, ANDROGEN; RISK FACTORS; TANDEM REPEAT SEQUENCES;

EID: 79958257548     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1263-7     Document Type: Article

References (46)

1. Norman AW, Litwack G (1987) Hormones. Academic Press, San Diego, CA
2. GE Abraham 1974 Ovarian and adrenal contribution to peripheral androgens during the menstrual cycle J Clin Endocrinol Metab 39 340 346 4278727 10.1210/jcem-39-2-340 1:CAS:528:DyaE2cXltFOqu7s%3D
3. EY Adashi 1994 The climacteric ovary as a functional gonadotropin-driven androgen-producing gland Fertil Steril 62 20 27 8005293 1:STN:280: DyaK2c3ntlyksA%3D%3D (Pubitemid 24198053)
4. C Longcope C Franz C Morello R Baker CC Johnston Jr 1986 Steroid and gonadotropin levels in women during the peri-menopausal years Maturitas 8 189 196 3097458 10.1016/0378-5122(86)90025-3 1:CAS:528:DyaL2sXhtlWhsA%3D%3D (Pubitemid 17170484)
5. G Rannevik S Jeppsson O Johnell B Bjerre, et al. 1995 A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density Maturitas 21 103 113 7752947 10.1016/0378-5122(94)00869-9 1:STN:280:DyaK2M3nt1CntQ%3D%3D
6. HG Burger EC Dudley J Cui L Dennerstein, et al. 2000 A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition J Clin Endocrinol Metab 85 2832 2838 10946891 10.1210/jc.85.8.2832 1:CAS:528: DC%2BD3cXnslahsL8%3D (Pubitemid 32269161)
7. EO Lillie L Bernstein G Ursin 2003 The role of androgens and polymorphisms in the androgen receptor in the epidemiology of breast cancer Breast Cancer Res 5 164 173 12793900 10.1186/bcr593 (Pubitemid 36519412)
8. T Key P Appleby I Barnes G Reeves Endogenous Hormones and Breast Cancer Collaborative Group 2002 Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies J Natl Cancer Inst 94 606 616 11959894 1:CAS:528:DC%2BD38Xjs1eit7w%3D (Pubitemid 34498648)
9. H Sasano M Kimura S Shizawa N Kimura, et al. 1996 Aromatase and steroid receptors in gynecomastia and male breast carcinoma: an immunohistochemical study J Clin Endocrinol Metab 81 3063 3067 8768875 10.1210/jc.81.8.3063 1:CAS:528:DyaK28XkvFWqtLw%3D (Pubitemid 26323909)
10. S Rajender L Singh K Thangaraj 2007 Phenotypic heterogeneity of mutations in androgen receptor gene Asian J Androl 9 147 179 17334586 10.1111/j.1745-7262.2007.00250.x 1:CAS:528:DC%2BD2sXlvVKlsrY%3D (Pubitemid 46416577)
11. R Wooster J Mangion R Eeles S Smith, et al. 1992 A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome Nat Genet 2 132 134 1303262 10.1038/ng1092-132 1:CAS:528: DyaK38XmtlWhtLs%3D
12. JM Lobaccaro S Lumbroso C Belon F Galtier-Dereure, et al. 1993 Androgen receptor gene mutation in male breast cancer Hum Mol Genet 2 1799 1802 8281139 10.1093/hmg/2.11.1799 1:CAS:528:DyaK2cXltFChsw%3D%3D (Pubitemid 23326602)
13. A Vermeulen JM Kaufman 1995 Ageing of the hypothalamo-pituitary- testicular axis in men Horm Res 43 25 28 7721258 10.1159/000184233 1:CAS:528:DyaK2MXjtF2nsrw%3D
14. A Morales JP Heaton CC Carson III 2000 Andropause: a misnomer for a true clinical entity J Urol 163 705 712 10687961 10.1016/S0022-5347(05)67788-9 1:CAS:528:DC%2BD3cXhsVSjur8%3D (Pubitemid 30091601)
15. A Kamischke A Baumgardt J Horst E Nieschlag 2003 Clinical and diagnostic features of patients with suspected Klinefelter syndrome J Androl 24 41 48 12514081 (Pubitemid 44698492)
16. AR Zinn P Ramos FF Elder K Kowal, et al. 2005 Androgen receptor CAGn repeat length influences phenotype of 47, XXY (Klinefelter) syndrome J Clin Endocrinol Metab 90 5041 5046 15956082 10.1210/jc.2005-0432 1:CAS:528: DC%2BD2MXhtVWkur7L (Pubitemid 41262252)
17. AR La Spada EM Wilson DB Lubahn AE Harding, et al. 1991 Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy Nature 352 77 79 2062380 10.1038/352077a0 1:CAS:528:DyaK3MXmt1Gju74%3D (Pubitemid 21896702)
18. DT Zava WL McGuire 1977 Estrogen receptors in androgen-induced breast tumor regression Cancer Res 37 1608 1610 192456 1:CAS:528:DyaE2sXktlOjtrk%3D (Pubitemid 8098497)
19. R Poulin D Baker F Labrie 1988 Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line Breast Cancer Res Treat 12 213 225 3242650 10.1007/BF01805942 1:CAS:528:DyaL1MXhs1Kgs7s%3D (Pubitemid 19019103)
20. J Ortmann S Prifti MK Bohlmann S Rehberger-Schneider, et al. 2002 Testosterone and 5 alpha-dihydrotestosterone inhibit in vitro growth of human breast cancer cell lines Gynecol Endocrinol 16 113 120 12012621 1:CAS:528:DC%2BD38XntVektbk%3D (Pubitemid 34496877)
21. R Hackenberg J Hofmann F Hölzel KD Schulz 1988 Stimulatory effects of androgen and antiandrogen on the in vitro proliferation of human mammary carcinoma cells J Cancer Res Clin Oncol 114 593 601 2974456 10.1007/BF00398183 1:STN:280:DyaL1M%2FnvFOnsg%3D%3D (Pubitemid 19011676)
22. M Marugo D Bernasconi L Miglietta L Fazzuoli, et al. 1992 Effects of dihydrotestosterone and hydroxyflutamide on androgen receptors in cultured human breast cancer cells (EVSA-T) J Steroid Biochem Mol Biol 42 547 554 1616884 10.1016/0960-0760(92)90268-N 1:CAS:528:DyaK38Xks1ehtbs%3D
23. R Azziz KS Woods R Reyna TJ Key, et al. 2004 The prevalence and features of the polycystic ovary syndrome in an unselected population J Clin Endocrinol Metab 89 2745 2749 15181052 10.1210/jc.2003-032046 1:CAS:528: DC%2BD2cXmtlGqurs%3D (Pubitemid 38766360)
24. Sobin LH, Wittekind CH (1997) TNM: classification of malignant tumours. In: International union against cancer, 5th edn. Wiley-Liss, New York
25. H Bloom W Richardson 1957 Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years Br J Cancer 11 359 377 13499785 10.1038/bjc.1957.43 1:STN:280:DyaG1c%2Fkt1Gmtg%3D%3D
26. K Thangaraj MB Joshi AG Reddy NJ Gupta, et al. 2002 CAG repeat expansion in the androgen receptor gene is not associated with male infertility in Indian populations J Androl 23 815 818 12399527 1:CAS:528:DC%2BD38XptV2hur4%3D (Pubitemid 36300971)
27. TR Rebbeck PW Kantoff K Krithivas S Neuhausen, et al. 1999 Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat Am J Hum Genet 64 1371 1377 10205268 10.1086/302366 1:CAS:528: DyaK1MXlt1ajt78%3D (Pubitemid 30468755)
28. AB Spurdle GS Dite X Chen CJ Mayne, et al. 1999 Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty years J Natl Cancer Inst 91 961 966 10359549 10.1093/jnci/91.11.961 1:CAS:528: DyaK1MXjvFOmtbw%3D (Pubitemid 29272523)
29. AM Dunning S McBride J Gregory F Durocher, et al. 1999 No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancer Carcinogenesis 20 2131 2135 10545416 10.1093/carcin/20.11.2131 1:CAS:528:DyaK1MXns1Kjtrw%3D (Pubitemid 29535315)
30. Y Giguère E Dewailly J Brisson P Ayotte, et al. 2001 Short polyglutamine tracts in the androgen receptor are protective against breast cancer in the general population Cancer Res 61 5869 5874 11479228 (Pubitemid 32769107)
31. L Kadouri DF Easton S Edwards A Hubert, et al. 2001 CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers Br J Cancer 85 36 40 11437399 10.1054/bjoc.2001.1777 1:CAS:528:DC%2BD3MXlvVKhtb0%3D (Pubitemid 32695713)
32. CA Haiman M Brown SE Hankinson D Spiegelman, et al. 2002 The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study Cancer Res 62 1045 1049 11861380 1:CAS:528:DC%2BD38XitVSmsb8%3D (Pubitemid 34160285)
33. NM Suter KE Malone JR Daling DR Doody, et al. 2003 Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women Cancer Epidemiol Biomarkers Prev 12 127 135 12582022 1:CAS:528:DC%2BD3sXhtVOlu7Y%3D (Pubitemid 36194002)
34. YA Elhaji B Gottlieb R Lumbroso LK Beitel, et al. 2001 The polymorphic CAG repeat of the androgen receptor gene: a potential role in breast cancer in women over 40 Breast Cancer Res Treat 70 109 116 11768600 10.1023/A: 1012942910375 1:CAS:528:DC%2BD38XmtVGntQ%3D%3D (Pubitemid 33139668)
35. A Anghel M Raica C Marian S Ursoniu, et al. 2006 Combined profile of the tandem repeats CAG, TA and CA of the androgen and estrogen receptor genes in breast cancer J Cancer Res Clin Oncol 132 727 733 16791593 10.1007/s00432-006- 0121-9 1:CAS:528:DC%2BD28XptVajs7Y%3D (Pubitemid 44337933)
36. A González F Javier Dorta G Rodriguez B Brito, et al. 2007 Increased risk of breast cancer in women bearing a combination of large CAG and GGN repeats in the exon 1 of the androgen receptor gene Eur J Cancer 43 2373 2380 17728127 10.1016/j.ejca.2007.07.001 (Pubitemid 47628900)
37. MH Wu YC Chou CP Yu T Yang, et al. 2008 Androgen receptor gene CAG repeats, estrogen exposure status, and breast cancer susceptibility Eur J Cancer Prev 17 317 322 18562955 10.1097/CEJ.0b013e3282f75e7f 1:CAS:528: DC%2BD1cXptVWnsLs%3D
38. A Liede W Zhang ML De Leon Matsuda A Tan, et al. 2003 Androgen receptor gene polymorphism and breast cancer susceptibility in The Philippines Cancer Epidemiol Biomarkers Prev 12 848 852 14504193 1:CAS:528:DC%2BD3sXnsValtrk%3D (Pubitemid 37151518)
39. W Wang EM John SA Ingles, et al. 2005 Androgen receptor and prostate-specific antigen gene polymorphisms and breast cancer in African-American women Cancer Epidemiol Biomarkers Prev 14 2990 2994 16365023 10.1158/1055-9965.EPI-05-0310 1:CAS:528:DC%2BD2MXhtlahs7jN (Pubitemid 43068836)
40. C Menin GL Banna G De Salvo V Lazzarotto, et al. 2001 Lack of association between androgen receptor CAG polymorphism and familial breast/ovarian cancer Cancer Lett 168 31 36 11368874 10.1016/S0304-3835(01)00473-6 1:CAS:528:DC%2BD3MXjsFejsb4%3D (Pubitemid 32463909)
41. E Dagan E Friedman T Paperna N Carmi, et al. 2002 Androgen receptor CAG repeat length in Jewish Israeli women who are BRCA1/2 mutation carriers: association with breast/ovarian cancer phenotype Eur J Hum Genet 10 724 728 12404104 10.1038/sj.ejhg.5200880 1:CAS:528:DC%2BD38XotFOrs70%3D (Pubitemid 35460581)
42. AB Spurdle AC Antoniou DL Duffy N Pandeya, et al. 2005 The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers Breast Cancer Res 7 R176 R183 15743497 10.1186/bcr971 1:CAS:528:DC%2BD2MXhtFSltbo%3D
43. DG Cox H Blanché CL Pearce EE Calle, et al. 2006 A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3) Breast Cancer Res 8 R54 16987421 10.1186/bcr1602 (Pubitemid 44669738)
44. ML Slattery C Sweeney J Herrick R Wolff, et al. 2007 ESR1, AR, body size, and breast cancer risk in Hispanic and non-Hispanic white women living in the Southwestern United States Breast Cancer Res Treat 105 327 335 17187234 10.1007/s10549-006-9453-z (Pubitemid 47596442)
45. FB De Abreu LJ Pirolo A Canevari Rde FE Rosa, et al. 2007 Shorter CAG repeat in the AR gene is associated with atypical hyperplasia and breast carcinoma Anticancer Res 27 1199 1205 17465263 (Pubitemid 46587041)
46. A Tsezou M Tzetis C Gennatas E Giannatou, et al. 2008 Association of repeat polymorphisms in the estrogen receptors alpha, beta (ESR1, ESR2) and androgen receptor (AR) genes with the occurrence of breast cancer Breast 17 159 166 17904846 10.1016/j.breast.2007.08.007 1:STN:280:DC%2BD1c3js1Cquw%3D%3D (Pubitemid 351467951)